Ironwood Pharma (IRWD) Reports Q1 Lost Per Share of 24c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.24), may note compare the analyst estimate of ($0.23). Revenue for the quarter came in at $28.9 million versus the consensus estimate of $32.3 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance
• Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance